Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Kay

Showing results (61-70 of 861) with videos related to

Pageof 87
Sort By:
Human Gene Therapy|December 16, 1998
Efficient construction of a recombinant adenovirus vector by an improved in vitro ligation methodH Mizuguchi, M A Kay
The Journal of Clinical Investigation|December 7, 2007
Therapeutic application of RNAi: is mRNA targeting finally ready for prime time?Dirk Grimm, Mark A Kay
Nature Medicine|September 1, 1995
Immunomodulation to enhance gene therapyC Wilson, M A Kay
Journal of Virology|May 1, 1996
Adenovirus-mediated expression of ribozymes in miceA Lieber, M A Kay
Molecular Medicine Today|March 1, 1997
Liver regeneration: prospects for therapy based on new technologiesM A Kay, N Fausto
Methods in Enzymology|February 10, 2015
Identification of small-molecule modulators of the circadian clockTsuyoshi Hirota, Steve A Kay
Science (New York, N.Y.)|March 7, 2015
RNA interference. Drugging RNAiDirk Haussecker, Mark A Kay
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 4, 2010
miR-122 continues to blaze the trail for microRNA therapeuticsDirk Haussecker, Mark A Kay
IEEE Transactions on Image Processing : a Publication of the IEEE Signal Processing Society|July 10, 2009
Color image segmentation by the vector-valued Allen-Cahn phase-field model: a multigrid solutionDavid A Kay, Alessandro Tomasi
British Medical Bulletin|April 1, 1995
Immunology of systemic rheumatoid diseaseN Snowden, R A Kay
Pageof 87

Showing results (61-70 of 861) with videos related to

Sort By:
Pageof 87
Human Gene Therapy|December 16, 1998
Efficient construction of a recombinant adenovirus vector by an improved in vitro ligation methodH Mizuguchi, M A Kay
The Journal of Clinical Investigation|December 7, 2007
Therapeutic application of RNAi: is mRNA targeting finally ready for prime time?Dirk Grimm, Mark A Kay
Nature Medicine|September 1, 1995
Immunomodulation to enhance gene therapyC Wilson, M A Kay
Journal of Virology|May 1, 1996
Adenovirus-mediated expression of ribozymes in miceA Lieber, M A Kay
Molecular Medicine Today|March 1, 1997
Liver regeneration: prospects for therapy based on new technologiesM A Kay, N Fausto
Methods in Enzymology|February 10, 2015
Identification of small-molecule modulators of the circadian clockTsuyoshi Hirota, Steve A Kay
Science (New York, N.Y.)|March 7, 2015
RNA interference. Drugging RNAiDirk Haussecker, Mark A Kay
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 4, 2010
miR-122 continues to blaze the trail for microRNA therapeuticsDirk Haussecker, Mark A Kay
IEEE Transactions on Image Processing : a Publication of the IEEE Signal Processing Society|July 10, 2009
Color image segmentation by the vector-valued Allen-Cahn phase-field model: a multigrid solutionDavid A Kay, Alessandro Tomasi
British Medical Bulletin|April 1, 1995
Immunology of systemic rheumatoid diseaseN Snowden, R A Kay
Pageof 87